Many individuals with Fragile X syndrome exhibit delays in development and can also have challenging behaviors, both of which can impact academic and daily functioning. Medications are sometimes helpful to facilitate the individual’s ability to attain optimal life skills and allow for better integration into educational, adult, and social environments.
There are several common symptoms and psychiatric conditions in individuals with Fragile X syndrome that are treated with the same medications used in the general population and individuals with other developmental disabilities. These medications have been reported to be effective for individuals with Fragile X syndrome in retrospective clinical studies. However, it’s important to note that there is limited formal research or clinical trial data to demonstrate the best approach to the use of medication specifically in the Fragile X syndrome population.
Dr. Craig Erickson, medical director at the Fragile X Clinic at Cincinnati Children’s Hospital Medical Center, joined us for our 10th annual webinar focused on medication for individuals with Fragile X syndrome.
Guided by moderator Jayne Dixon Weber, Dr. Erickson shares the latest updates on medications and research followed by a Q&A session. He provides a wealth of information for various ages, behaviors, and medications.
The latest treatment recommendation, Medications for Individuals with Fragile X Syndrome, provides additional information on many of the medications discussed during the webinar.